Doxorubicin (DOX) is one of the most widely used chemotherapy drugs in the treatment of both solid and liquid tumors in patients of all age groups. However, it is likely to produce several side effects that include doxorubicin cardiomyopathy. Nanoparticles (NPs) can offer targeted delivery and release of the drug, potentially increasing treatment efficiency and alleviating side effects. This makes them a viable vector for novel drug delivery systems. Currently, DOX is commonly conjugated to NPs by non-covalent conjugation–physical entrapping of the drug using electrostatic interactions, van der Waals forces, or hydrogen bonding. The reported downside of these methods is that they provide a low drug loading capacity and a higher drug leakage possibility. In comparison to this, the covalent conjugation of DOX via amide (typically formed by coupling carboxyl groups on DOX with amine groups on the nanoparticle or a linker, often facilitated by carbodiimide reagents), hydrazone (which results from the reaction between hydrazines and carbonyl groups, offering pH-sensitive cleavage for controlled release), or disulfide bonds (formed through the oxidation of thiol groups and cleavable by intracellular reducing agents such as glutathione) is more promising as it offers greater bonding strength. This review covers the covalent conjugation of DOX to three different types of NPs—metallic, silica/organosilica, and polymeric—including their corresponding release rates and mechanisms.

This study comprises the comprehensive toxicological assessment of thiolated organosilica nanoparticles (NPs) synthesised from 3-mercaptopropyltrimethoxysilane (MPTS). We investigated the influence of three different types of nanoparticles synthesised from 3-mercaptopropyltrimethoxysilane: the starting thiolated silica (Si-NP-SH) and their derivatives prepared by surface PEGylation with PEG 750 (Si-NP-PEG750) and 5000 Da (Si-NP-PEG5000m) on biological subjects from in vitro to in vivo experiments to explore the possible applications of those nanoparticles in biomedical research. As a result of this study, we generated a comprehensive understanding of the toxicological properties of these nanoparticles, including their cytotoxicity in different cell lines, hemolytic properties, in vitro localisation, mucosal irritation properties and biodistribution in BALB/c mice. Our findings indicate that all three types of nanoparticles can be considered safe and have promising prospects for use in biomedical applications. Nanoparticles did not affect the viability of HPF, MCF7, HEK293 and A549 cell lines at low concentrations (up to 100 µg/mL); moreover, they did not cause organ damage to BALB/c mice at concentrations of 10 mg/kg. The outcomes of this study enhance our understanding of the impact of organosilica nanoparticles on health and the environment, which is vital for developing silica nanoparticle-based drug delivery systems and provides opportunities to expand the applications of organosilica nanoparticles.

Carbon dot-based radiocontrast agents have recently sparked the interest of researchers owing to their better contrasting capabilities, simple synthesis protocols, high colloidal stability, and good biocompatibility. In this study, we propose for the first time the synthesis of iodine-doped carbon dots (I-CDs) using low-cost reagents such as citric acid (C₆H₈O₇), urea (CH₄N₂O) and potassium iodide (KI). The as-prepared I-CDs demonstrated excellent colloidal stability (with a zeta potential value of −64.7 mV), excitation-dependent fluorescent properties (with a maximum quantum yield of ∼8.9%), and a mean iodine concentration of ∼4.67 wt%. Notably, the as-prepared I-CDs displayed greater X-ray attenuation efficiency (42.87 HU mL mg⁻¹) as compared to the commercially employed iopromide radiocontrast agent (30.98 HU mL mg⁻¹). Furthermore, ATPase activity, cytotoxicity analysis with HeLa, NHDF, HEK293, and A549 cell lines, and live-cell imaging experiments of the Drosophila neuroblasts in intact brain lobes suggested high biocompatibility and nontoxicity of the prepared I-CDs. Overall, biocompatible and low-cost I-CDs show great promise as bifunctional radiocontrast and fluorescent agents for biomedical applications.

Doxorubicin (DOX) is one of the most widely used chemotherapy drugs in the treatment of both solid and liquid tumours in patients of all age groups. However, it is likely to produce several side effects that include doxorubicin cardiomyopathy. Nanoparticles (NPs) can offer targeted delivery and release of the drug, potentially increasing the treatment efficiency and alleviating the side effects. This makes them a viable vector for novel drug delivery systems. Currently, DOX is commonly conjugated to NPs by non-covalent conjugation – physical entrapping of the drug using electrostatic interactions, van der Waals forces, or hydrogen bonding. The reported downside of these methods is that they provide low drug loading capacity and higher drug leakage possibility. In comparison to this, covalent conjugation of DOX via amide, hydrazone, or disulfide bonds is more promising, as it offers greater bonding strength. This review covers the covalent conjugation of DOX to three different types of NPs – metallic, silica/organosilica, and polymeric, including their corresponding release rates and mechanisms.

Background/Objectives: Surface chemistry is a major determinant of nanoparticle–cell interactions, yet their influence on mechanobiological properties of cells remains incompletely understood. This study investigated the cytotoxic and mechanobiological effects of thiolated and PEGylated organosilica nanoparticles and evaluated whether cortical stiffness could serve as a complementary measure of nanoparticle–cell interactions. Methods: We evaluated thiolated organosilica nanoparticles (Si NP-SH) and two PEGylated nanoparticles (Si NP-PEG750 and Si NP-PEG5000) in non-cancerous human pulmonary fibroblasts (HPF) and cancerous human pulmonary adenocarcinoma (A549) cells. We assessed cellular viability and nanoparticle uptake after exposure and used atomic force microscopy to measure cellular cortical stiffness. Additionally, nanoparticle effects on neuroblast proliferation and mitotic progression were examined in Drosophila melanogaster larval brain explants. Results: HPF cells were markedly less sensitive to all nanoparticle formulations across the tested concentration range, whereas A549 cells showed dose-dependent sensitivity, with thiolated nanoparticles producing the earliest and greatest reduction in viability. Despite a comparable uptake of Si NP-SH and Si NP-PEG750, the thiolated nanoparticles produced greater toxicity, whereas Si NP-PEG5000 showed lower uptake but intermediate toxicity. Atomic force microscopy measurements demonstrated significant cortical softening in Si NP-SH-treated A549 cells, while HPF cells were unaffected. All nanoparticles reduced Drosophila melanogaster neuroblast proliferation in a similar order: Si NP-SH > Si NP-PEG750 > Si NP-PEG5000. Conclusions: The biological activity of organosilica nanoparticles is predominantly dependent on accessibility and intracellular reactivity of surface thiols rather than uptake alone. PEGylation shields thiol reactivity, with higher PEG molecular weight additionally reducing nanoparticle uptake. The consistency of viability, uptake, cortical stiffness, and neuroblast proliferation identifies AFM-derived cortical stiffness as a valuable complementary measurement of nanoparticle-induced stress.